Disease | hepatocellular carcinoma |
Phenotype | |cirrhosis |
Sentences | 171 |
PubMedID- 24893685 | Background: an association between transjugular intrahepatic porto-systemic shunt (tips) and the development of hepatocellular carcinoma in patients with cirrhosis has been suggested, but not confirmed. |
PubMedID- 21881927 | Of the remaining ten patients, four had hepatitis c-related cirrhosis (one also with hepatocellular carcinoma), three had alcoholic cirrhosis, two had primary biliary cirrhosis, and one had non-alcoholic, fatty liver disease-associated cirrhosis. |
PubMedID- 23768738 | Background: liver resection for hepatocellular carcinoma (hcc) combined with nash -related cirrhosis has become increasingly common. |
PubMedID- 26166077 | Magnetic resonance spectroscopy was used as a means of predicting the probability of developing hepatocellular carcinoma (hcc) in patients with liver cirrhosis secondary to chronic hepatitis b.this study included 20 healthy volunteers, 20 patients with liver cirrhosis secondary to chronic hepatitis b (cirrhosis group), and 20 patients with small hcc secondary to cirrhosis liver parenchyma (hcc group). |
PubMedID- 22056847 | Hepatitis b virus (hbv) infection has a wide variety of clinical outcomes, it could be spontaneouly recovered and also could develop fulminant liver failure or cirrhosis with hepatocellular carcinoma. |
PubMedID- 23146511 | Introduction: the coexistence of liver cirrhosis with hepatocellular carcinoma (hcc) and colon cancer (ca), which is a rare clinical condition, was treated in a liver transplant recipient. |
PubMedID- 25785114 | Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with hbv-associated liver cirrhosis in china. |
PubMedID- 22483505 | The patient was a 62-year-old man, who suffered decompensated liver cirrhosis with hepatocellular carcinoma. |
PubMedID- 25465804 | The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma. |
PubMedID- 25436303 | As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure. |
PubMedID- 24352343 | There were 383 patients with cirrhosis associated with hepatocellular carcinoma (hcc). |
PubMedID- 25473157 | These include those with underlying cirrhosis, severe flares of chb, hepatocellular carcinoma (hcc), and for those undergoing liver transplantation. |
PubMedID- 24932302 | Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: a report of two cases. |
PubMedID- 22778970 | In the present systematic review, we explore the different aspects of the management of pvt in individuals with cirrhosis (excluding cases associated with hepatocellular carcinoma). |
PubMedID- 20004441 | Background: the choice between minor versus major resection or anatomic versus nonantatomic resection for small (<5 cm) solitary hepatocellular carcinoma (hcc) in patients with cirrhosis is controversial. |
PubMedID- 24034029 | Background: liver transplantation (olt) is the gold standard therapy for patients with cirrhosis complicated by hepatocellular carcinoma (hcc) within milan criteria (mc). |
PubMedID- 22982095 | Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. |
PubMedID- 24229043 | A 69-year-old woman, who underwent cadaveric liver transplantation for non-b, non-c liver cirrhosis with hepatocellular carcinoma in april 2009, was admitted to our hospital because of graft dysfunction. |
PubMedID- 22363353 | Some individuals with persistent hcv infections develop liver cirrhosis, which can lead to hepatocellular carcinoma in some patients [1][2][3][4]. |
PubMedID- 24815863 | Because cirrhosis underlies most cases of hepatocellular carcinoma (hcc) and advanced cirrhosis can, in fact, affect patients’ survival to a greater degree than the carcinoma itself (3,4), the ctp score has become the standard prognostic tool for predicting survival and for assessing hepatic reserve to guide initial or subsequent therapy decisions by predicting risk of liver failure and death after local and systemic therapies and for categorizing patients under hcc staging systems for trial entry (5). |
PubMedID- 21896165 | In 40-60% of hcv-infected individuals, chronic infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) [3,4]. |